E-LIB Suche - Ergebnisse für: Hurvitz, Sara A

1

Pembrolizumab-induced nephrotoxicity in a patient with brea..:

Alkassis, Samer ; Fitzsimmons, Kasey ; Hurvitz, Sara
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

2

Author Correction: Safety analyses from the phase 3 ASCENT ..:

Rugo, Hope S. ; Tolaney, Sara M. ; Loirat, Delphine...
npj Breast Cancer. 10 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

Type I interferons, inflammation, and fatigue in a longitud..:

Bower, Julienne E. ; Ganz, Patricia A. ; Irwin, Michael R....
Brain, Behavior, and Immunity. 118 (2024) - p. 312-317 , 2024

Link: https://doi.org/10.1016/..

4

Subgroup analyses from the phase 3 ASCENT study of sacituzu..:

Hurvitz, Sara A. ; Bardia, Aditya ; Punie, Kevin...
npj Breast Cancer. 10 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

5

Author Correction: Subgroup analyses from the phase 3 ASCEN..:

Hurvitz, Sara A. ; Bardia, Aditya ; Punie, Kevin...
npj Breast Cancer. 10 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

6

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2..:

Cortés, Javier ; Hurvitz, Sara A. ; Im, Seock-Ah...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

7

Landscape of Baseline and Acquired Genomic Alterations in C..:

Goetz, Matthew P. ; Hamilton, Erika P. ; Campone, Mario...
Clinical Cancer Research. 30 (2023) 10 - p. 2233-2244 , 2023

Link: https://doi.org/10.1158/..

8

Rationale and trial design of NATALEE: a Phase III trial of..:

Slamon, Dennis J. ; Fasching, Peter A. ; Hurvitz, Sara...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

9

DESTINY-Breast03 trial: some questions remain – Authors' re..:

Hurvitz, Sara A ; Curigliano, Giuseppe ; Egorov, Anton..
The Lancet. 401 (2023) 10389 - p. 1653-1654 , 2023

Link: https://doi.org/10.1016/..

10

Health-related quality of life in the phase III ASCENT tria..:

Loibl, Sibylle ; Loirat, Delphine ; Tolaney, Sara M....
European Journal of Cancer. 178 (2023) - p. 23-33 , 2023

Link: https://doi.org/10.1016/..

11

Trastuzumab deruxtecan versus trastuzumab emtansine in pati..:

Hurvitz, Sara A ; Hegg, Roberto ; Chung, Wei-Pang...
The Lancet. 401 (2023) 10371 - p. 105-117 , 2023

Link: https://doi.org/10.1016/..

12

Genomic analysis of advanced breast cancer tumors from tala..:

Turner, Nicholas C. ; Laird, A. Douglas ; Telli, Melinda L....
npj Breast Cancer. 9 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

13

Final findings from the CONTROL trial: Strategies to reduce..:

Chan, Arlene ; Ruiz-Borrego, Manuel ; Marx, Gavin...
The Breast. 67 (2023) - p. 94-101 , 2023

Link: https://doi.org/10.1016/..

14

Tumor biomarkers and efficacy in patients treated with tras..:

de Haas, Sanne L. ; Slamon, Dennis J. ; Martin, Miguel...
Breast Cancer Research. 25 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

15

Neoadjuvant palbociclib plus either giredestrant or anastro..:

Hurvitz, Sara A ; Bardia, Aditya ; Quiroga, Vanesa...
The Lancet Oncology. 24 (2023) 9 - p. 1029-1041 , 2023

Link: https://doi.org/10.1016/..